The Manufacturers Life Insurance Company trimmed its position in shares of Littelfuse, Inc. (NASDAQ:LFUS – Free Report) by ...

As winter approaches and forecasts predict an especially cold season this year, room heaters have become essential in ...

The best smart beds and mattresses allow you to effortlessly combat the issues keeping you awake at night, allowing you to supercharge your sleep. While our guide to the year’s best mattresses ...

They mapped all the cells critical for skull formation and examined how genetic mutations may cause soft spots in a newborn baby’s skull to fuse too early, constraining the developing brain’s ...

PTC 19 has formed into Tropical Depression 19 as it moves through the Caribbean. The NHC predicts it will intensify into Tropical Storm Sara as it moves toward Central America this week.

Now, seven years and many approvals later, innovation in the space has hit new heights with PTC Therapeutics’ Kebilidi, the first U.S. gene therapy that’s administered directly in the brain.

On Wednesday, PTC 19, formerly known as Invest 99L, was over 400 miles east of Isla Guanaja, Honduras, and 290 miles east-northeast of Cabo Gracias A Dios, near the Honduras-Nicaragua border ...

The FDA has followed in the footsteps of its European counterparts and granted accelerated approval to PTC Therapeutics’ gene therapy Kebilidi for AADC deficiency. It is the first approved gene ...

Credit: Gatot Adri via Shutterstock. The US Food and Drug Administration (FDA) has granted accelerated approval for PTC Therapeutics’ KEBILIDI, the first gene therapy in the US that is directly ...

WARREN, N.J., Nov. 13, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today the U.S. Food and Drug Administration (FDA) accelerated approval of its gene therapy for the ...